Interleukin 4 (also known as "B cell stimulatory factor-1"), a cytokine product of T lymphocytes and mast cells, stimulates synthesis of the extracellular matrix proteins, types I and III collagen and fibronectin, by human dermal fibroblasts in vitro. Stimulation of collagen by human recombinant (hr)IL-4 was also demonstrated in several fibroblastic synovial cell lines obtained from patients with rheumatoid arthritis and osteoarthritis. The stimulatory effect of hrIL-4 on fibroblast collagen synthesis was specifically neutralized by rabbit anti-hrIL-4 Ig. IL-4 specifically increased the steady-state levels of types I and III procollagen and fibronectin mRNAs, with no effect on cytoplasmic beta-actin mRNA. Quantitative analysis of the levels of Pro alpha 1(I) collagen transcripts in IL-4-treated fibroblast cultures was also corroborated by antisense RNA-mRNA hybridization and RNAse resistant hybrids which showed that IL-4-treated fibroblasts expressed higher levels of Pro alpha 1(I) collagen transcripts. Nuclear run-off transcription experiments indicated that IL-4 stimulated the rates of mRNA biogenesis. Based on these observations we conclude that IL-4 exerts its effect on collagen and fibronectin synthesis at the pretranslational level, resulting in synthesis of these extracellular matrix proteins. These and other data suggest that IL-4 may be a "fibrogenic cytokine" that could be important in promoting biogenesis of extracellular matrix proteins in normal wound healing and in pathological fibrosis in which mast cells and T lymphocytes play […]
Introduction
Interleukin 4 (IL-4) is a T lymphocyte and mast cell product that was originally recognized as a factor required for DNA synthesis by resting murine B cells stimulated by low concentrations of anti-Ig antibodies ( 1) . Originally named "B cell stimulatory factor-1", it is identical to IgGl factor, B cell growth factor-y, mast cell growth factor-2, and T cell growth factor-2 (2) (3) (4) . IL increases class II antigen expression, and promotes growth of IL-2-dependent T cell lines (5) (6) (7) (8) (9) . IL-4 receptors have been identified on hematopoietic cells such as normal B cells, resting and activated T cells, macrophages, and mast cell tumor lines (10) .
Fibroblasts have receptors for . Under some conditions, murine dermal and lung fibroblasts have been demonstrated to proliferate in the presence of murine IL-4 ( 13) . Human fibroblasts chemotax in the presence ofhuman recombinant (hr)'IL-4 (14) . We report here that IL-4 is also capable of stimulating extracellular matrix protein biosynthesis in human dermal and synovial fibroblasts. Elevation of steady-state levels of types I and III procollagen and fibronectin mRNAs in IL-4-treated cells suggests that this cytokine regulates extracellular matrix biogenesis by pretranslational mechanisms. Fibroblast cultures. Primary cultures of human fibroblasts were established from explants of infant foreskins and were maintained in monolayer by standard techniques. Primary cultures of human synovial fibroblastic cells were developed from explants of synovial tissue removed from patients with RA and osteoarthritis (OA) at the time of surgery for joint replacement ( 15). Patients with OA had end stage disease requiring arthroplasty and were all receiving nonsteroidal antiinflammatory drugs (NSAIDS). The patients with RA had active disease with marked joint destruction. They were all being treated with NSAIDS and remittive agents including gold salts, azathioprine, or methotrexate. Cells were grown in 100-mm diameter petri dishes in Eagle's MEM supplemented with 9% FCS, nonessential amino acids, penicillin (100 U/ml), streptomycin (100 ,g/ml), ascorbic acid (50 ,ug/ml), amphotericin B (1 Ag/ml) and Earle's salts. Eagle's MEM with these supplements is hereafter referred to as "maintenance medium." Cultures were routinely passaged after trypsinization every 3-5 d.
Interleukin 4. HrIL-4 produced in yeast (16, 17) was purchased from Genzyme Corp., Boston, MA. The hrIL-4 preparations used were judged to be > 95% pure by silver staining of SDS-PAGE gels.
Quantitation ofcollagenous and noncollagenous protein synthesis.
Fibroblasts were seeded (5 x 104 cells/0.5 ml maintenance medium) in wells of 3424 Mark II Cluster plates (Costar Corp., Cambridge, MA) and grown for 72 h to reach confluency. To minimize effects of serum growth factors and factors that stimulate collagen synthesis, all cultures in which the effects ofIL-4 on collagen production were measured were performed in serum-free medium as indicated. After the initial 72-h culture, the medium in each well was replaced with 500 Al serum-free maintenance medium containing fresh ascorbic acid (50 sg/ml); 24 h later, medium was replaced with 450 ,l fresh serum-free maintenance medium (minus nonessential amino acids) containing ascorbic acid and either PBS or different concentrations of hrIL-4 in PBS (50-Ml vol each). 24 h later, cultures were pulsed with fresh serum-free maintenance medium (minus nonessential amino acids) containing 5.0 MCi [2, 3-3H]proline (sp act 20 Ci/mmol). After a 24-h labeling period, supernatants from each well were harvested and assayed for levels of collagenase-sensitive protein as previously described (18) . For SDS-PAGE analysis of newly synthesized proteins, confluent fibroblast cultures (100-mm diameter petri dishes) were grown for one day in serum-free maintenance medium containing fresh ascorbic acid. Medium was then replaced with serum-free maintenance medium containing fresh ascorbic acid (minus nonessential amino acids) with or without hrIL-4 (2. (19) (20) (21) . Isolation and quantitation of messenger RNAs. Confluent fibroblasts (72 h after plating) in 100-mm diameter petri dishes were treated with hrIL-4 (2.5 ng/ml). After 48 h, total RNA was extracted by using RNAZOL (Cinna/Biotecx, Friendswood, TX). The quality and quantity of RNA were routinely tested by determining A260/A2go and ethidium bromide fluorescence of RNA electrophoresed in agarose gels. Serial dilutions of total RNA were immobilized on nitrocellulose and subjected to prehybridization and hybridization as described previously (19, 20, 22) . Quantitation ofantisense RNA-mRNA hybridization and RNAseresistant hybrids. Total RNA extracted from the control or IL-4-treated cell monolayers was hybridized to a radiolabeled antisense riboprobe. A 550-bp EcoRI-Aval fragment removed from human Pro a I (I) collagen cDNA clone HF677 (23) was cloned into the multiple cloning site of PSP6/T7-19 plasmid (24) . Sense or antisense riboprobes were generated by in vitro transcription using SP6 and T7 RNA polymerase (24) . Hybridization in a final vol of 30 Ml was carried out with the radiolabeled antisense RNA as probe (3 X 105 cpm) and increasing amounts (0.5-5.0,ug) oftotal RNA isolated from human fibroblasts in hybridization buffer (80 mM formamide, 40 mM piperazine-N,N'bis(2-ethane sulfonic acid) pH 6.4, 400 mM NaCl, 1 mM EDTA). RNA samples were heated to 85°C for 5 min and then incubated at 60°C overnight. Samples were incubated (30 min at 30°C) in ribonuclease digestion buffer containing 40 Mg/ml RNase and 2 Mg/ml RNase T1. This was followed by addition of 10 ML of 20% SDS, 25 MlI of 20 mg/ml proteinase K, and then by further incubation for 15 min at 37°C. Radiolabeled RNase-resistant hybrids were purified by phenol/ chloroform extraction and ethanol precipitation and were then analyzed either by denaturing polyacrylamide/urea gel or by directly counting in a scintillation spectrometer.
Nuclear run-off assays. Nuclei from control or IL-4 treated cells ( 1-2 X I0') were incubated in vitro in 100 Ml reaction mixture which contained 10% glycerol, 50mM Tris-HCI, pH 8.0, 5 mM MgCl2, 1 mM each of ATP, GTP, and CTP, and 250 MCi of [ a-32P]UTP at 250C for 30 min. Radiolabeled transcripts were extracted and hybridized to DNA immobilized on nitrocellulose filters. The detailed methodology for nuclear run-off assays has been described previously ( 19) and was used with minor modifications.
Results
Effect ofhrIL-4 on collagen andfibronectin synthesis. Purified hrIL-4 stimulated production of collagen by dermal fibroblasts in a dose-dependent fashion with maximal stimulation occurring at 2.5 ng/ml ( Fig. 1 ). Although the magnitude of the response varied with different cell lines, a similar dose-dependence to hrIL-4 was displayed by all dermal and synovial fibroblasts tested. This heterogenous response is evident in data shown in Table I wherein some dermal and synovial fibroblast lines exhibited modest increases in collagen production while others increased their production of collagen by as much as fourfold. Interestingly, hrIL-4 did not stimulate growth ofconfluent fibroblasts under the culture conditions used to quantitate collagen production ( Table I) .
The effect of hrIL-4 at doses of 2-10 ng/ml on collagen production was assessed in 82 additional dermal and 22 (13 RA and 9 OA) additional synovial fibroblast lines. 87% of the dermal fibroblast lines and 83% of the synovial fibroblast lines ( 12 of 13 RA and 6 of 9 OA) produced significantly increased amounts ofcollagen in response to hrIL-4 (data not shown). In addition, we observed that the stimulatory effect of hrIL-4 on collagen production was reproduced when the same cell lines were tested on different days (Table I) , and in some cases this IL-4 responsiveness was retained in fibroblasts maintained for up to 3 mo and for 10 subpassages in culture (data not shown).
The stimulatory effect of hrIL-4 on fibroblast collagen synthesis was neutralized by pretreatment of hrIL-4 with anti-hrIL-4 immunoglobulin (Table II) . Specificity ofthe antibody to block this hrIL-4-mediated response was further attested to by the fact that anti-hrIL-4 antibody treatment of hrIL-l did not inhibit collagen production induced by this unrelated cytokine (Table II) ND ND ND ND Infant foreskin (HF) and synovial fibroblast lines (RA and OA) were cultured in triplicate at confluency for 48 h in serum-free maintenance medium without nonessential amino acids with or without hrIL-4 (2 ng/ml) as described in Methods. The medium was analyzed for collagen levels by quantitating the amount of [3H]proline incorporated into collagenase-sensitive protein as described in Methods. The cell layer in each multiwell plate well was removed by trypsinization, and the number of cells in each well was quantitated by use of a hemacytometer. Statistical significance of results obtained in culture treated with hrIL-4 and PBS was determined by use of the two-sample Student's t test. * These cell lines were restudied 1-4 wk later. * hrIL-4 concentration 0.5 ng/ml. fibronectin synthesis by pulse labeling dermal fibroblast monolayers with either [3H ] proline or [35S ] methionine. SDS-PAGE and fluorography were used to analyze the radiolabeled polypeptides. Comparative quantitative analysis of total cellular (cell associated and extracellularly released combined) and ex-tracellularly released polypeptide synthesis is shown in Fig. 2 and Table III . IL-4 had a two-to threefold stimulatory effect on the synthesis of both secreted type I procollagen and fibronectin. Although not shown here, IL-4 appeared to have similar stimulatory effect on the synthesis ofboth types I and III colla- For experiment 1, two 250-Al aliquots each of hrIL-4 (7.5 ng) or hrIL-lf (300 pg) were separately incubated overnight at 4VC with either 15 Ml of MEM or ofrabbit anti-hrIL-4 Ig (15 5tg), and each was then added to separate triplicate wells (Mark II plates; Costar Corp.) (2.5 ng/ml) hrIL-4 and 100 pg hrIL-l1 final concentration of confluent fibroblast monolayers for 48 h, and collagen production was quantitated by the collagenase-sensitive protein technique as described in Methods. For experiment 2, a similar protocol was used but IL-lI3 was omitted. t Statistical significance was assessed by use of the two-sample Student's t test. For experiment 1 and experiment 2, collagen production by media-treated fibroblasts was compared to collagen production by fibroblasts treated with hrIL-4 plus media.
Collagen production by fibroblasts treated with hrIL-4 preincubated with anti-hrIL-4 Ig was compared to collagen production by fibroblasts treated with hrIL-4. Also for experiment 1, collagen production by fibroblasts treated with hrIL-I plus media was compared to collagen production by fibroblasts treated with hrIL-l that had been preincubated with anti-hrIL-4 Ig.
gen (our unpublished data). The effect was preferential on extracellular matrix polypeptides released in the medium since little or no change was apparent in the synthetic rates of total cellular polypeptides, labeled either with [35S ] methionine (Fig.  2 , Table III ) or with [3H]proline (data not shown).
IL-4 effect on the steady-state accumulation oftypes I and III procollagen and fibronectin mRNAs. It was of interest to determine whether the observed increases in synthesis of collagen and fibronectin in IL-4-treated fibroblasts was reflected in the steady-state levels of their respective mRNAs. Therefore, an equal amount of total extracted RNA was size fractionated in denaturing gels and stained with ethidium bromide. RNA was then transferred onto nitrocellulose filters and probed with nick-translated cDNA plasmids specific for Pro a I (I) and Pro a1(III) collagens. A representative example of an ethidium bromide-stained gel and a sequential Northern analysis using Pro a 1(I) collagen and Pro a 1 (III) collagen probes is shown in Fig. 3 . In addition to Northern analysis, we also immobilized these samples by slot-blot hybridized to various cDNAs and quantitated the steady-state levels ofvarious mRNAs. Densitometric analysis of the autoradiograms from these slot-blot hybridizations (Fig. 4) showed that hrIL-4 caused over a twofold increase in Pro a 1(I ) collagen mRNA and an -40% increase in fibronectin mRNA with no effect on ,B-actin mRNA (Table   IV) . Steady-state levels of Pro a1 (111) collagen mRNAs were also increased by hrIL-4, and the extent ofthis stimulation was similar to that observed for Pro a 1(I) collagen mRNAs (Fig. 3 and data not shown). The variable response to hrIL-4 from culture to culture and cell line to cell line noted in the collagenase-sensitive protein data in Table I was gen transcripts in hrIL-4 (2.5 ng/ml)-treated dermal fibroblast cultures was also corroborated by antisense RNA-mRNA hybridization and RNAse resistant hybrids which showed that hrIL-4-treated fibroblasts expressed higher levels of Pro a 1(I) collagen transcripts (Fig. 5) . To investigate the level of regulation of extracellular matrix genes, nuclear run-off analysis was performed (Fig. 6) ; filter-immobilized DNA, representing Pro a 1(I) collagen, Pro a 1 (111) collagen, and fibronectin was hybridized with radiolabeled run-off transcripts isolated from the nuclei of untreated and IL-4-treated cells. These data revealed that the rates of transcription of Pro a1(I) collagen, Pro a 1 (111) collagen, and fibronectin were preferentially increased after IL-4 treatment (Fig. 6) . vealed about a threefold increase in the rates of transcriptions of the Pro a 1 (I) collagen gene; transcription of Pro a 1 (111) collagen and fibronectin genes were affected by hrIL-4 to a much lesser extent ( 1.8-to 2.0-fold). The nuclear run-off experiment was repeated three times and similar results were obtained (data not shown). Therefore, it would appear that the observed alterations in the rates of steady-state accumulation of various transcripts could be fully accounted for by changes in the rates of transcription after hrIL-4 treatment.
Discussion
The synthesis of the matrix components, type I and type III collagen and fibronectin, by dermal fibroblasts was stimulated Fig. 4 expressed by an integrator (3390A; Hewlett-Packard). Results are then expressed as treated/control X 100.
by hrIL-4. Fibroblasts from the synovium of patients with RA or OA also responded to hrIL-4 with stimulation of collagen production. Highly specific anti-hrIL-4 antibodies neutralized the collagen-stimulating property ofhrIL-4. Stimulation ofcollagen and fibronectin synthesis by IL-4 is associated with increased steady-state levels oftheir cognate mRNA levels resulting from enhanced rates of transcription of the target genes. Receptors for IL-4 are present on a variety of different cell types, and it is not surprising that this T celland mast cellderived cytokine, which was originally named B-cell stimulatory factor-l for its ability to act as a costimulant with antiimmunoglobulins for resting B cells, is being increasingly recognized as having a plethora of activities (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The effects of IL-4 on fibroblast functions may have important implications for a normal healing host response to tissue injury as well as for several human fibrosing diseases. Mast cells, which are a source of IL-4, are closely associated with inflammation and the fibrotic response (see reference 25 for review). In normal wound healing, mast cell infiltration of the injury site parallels the accumulation offibroblasts and matrix deposition (25) . It is of interest that conditions considered to be aberrant types of wound healing (hypertrophic scars and keloids) are associated with increased numbers of mast cells in these abnormal tissues (25) . There is a striking association ofmast cell accumulations in fibrotic lesions of other disease states, including chronic inflammation (e.g., parasitic diseases, psoriasis, interstitial pulmonary fibrosis, and rheumatoid synovium), tumors (e.g., carcinoid, hemangiomas, neurofibromas, and mastocytosis), and scleroderma and related syndromes such as toxic oil syndrome, eosinophilic fasciitis, chronic graft-versus-host disease, and bleomycin-induced fibrosis (reviewed in 25) . T cells are also intimately associated with the fibrotic response in many of these same diseases (e.g., parasitic disease, interstitial pulmonary fibrosis, rheumatoid synovium, scleroderma, and chronic graft-versus-host disease [26] [27] [28] [29] ). Serum levels of IL-4 have been reported to be elevated in patients with scleroderma (30) .
The effect of IL-4 on fibroblasts is not limited to stimulation ofmatrix protein synthesis but also includes stimulation of growth of subconfluent fibroblasts and induction of chemotaxis of these cells ( 13, 14) . The present study suggests that IL-4 should be viewed as a fibrogenic cytokine that may be Figure 6 . An autoradiogram depicting the results of a nuclear run-off transcription assay. Nuclei isolated from control or hrIL4-treated fibroblasts were incubated in an in vitro transcription run-off buffer and the radiolabeled transcripts were purified. Linearized DNA was immobilized on a nitrocellulose filter and subjected to hybridization with 32P-labeled transcripts as detailed previously ( 19) . Nonspecific hybridization was determined from radioactivity bound to pBR322 DNA. elaborated by T cells and/or mast cells at sites of immune and inflammatory reactions. IL-4 could then act locally to recruit fibroblasts from neighboring sites to the area where they are further stimulated to proliferate and synthesize collagen and fibronectin. IL-4 may play a significant role in directing repair processes that maintain integrity of the host in health but which may be deleterious in fibrotic diseases. The fact that synovial fibroblasts also synthesize increased amounts ofcollagen in the presence ofIL-4 suggests that these cells could potentially elaborate increased amounts of collagen characteristic of thickened synovial membranes that accompany some forms of arthritis, perhaps in which mast cells and T cells are activated. Future studies should clarify these issues.
